Why the study?
Does intravenous ondansetron reduce postsurgical opioid-induced nausea and vomiting in patients undergoing regional anesthesia?
Population
ASA physical status I-III patients undergoing regional anesthesia who requested an antiemetic after…
Comparison
Single dose of ondansetron vs Placebo
Design
RCT, randomized, double-blind
Follow-up
24 h
Authors
Loading...
Supports ondansetron for opioid-induced PONV after regional anesthesia; confirms efficacy in this RCT.
Does intravenous ondansetron reduce postsurgical opioid-induced nausea and vomiting in patients undergoing regional anesthesia?
A single intravenous dose of ondansetron (4 mg or 16 mg) is effective for treating postsurgical opioid-induced nausea and vomiting.
Rung et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: